Making the discoveries that defeat cancer

  • Home |
  • About Us  |
  • Research  |
  • Enterprise  |
  • Education  |
  • Jobs  |
  • Support Us  |
  • News  |
  • Contact Us
  • Home »
  • News

News

  • Cancer Voices
  • Press Release Archive
  • PR Contacts
  • Recent Featured Articles
  • Research Highlights
Gloved hands on microscope

Featured Article

Untangling the evolution of cancer
Here at the ICR, Professor Mel Greaves applies evolutionary thinking to illuminate how cancers work.
Read More

Recent Featured Articles

  • Breast cancer patients with gene fault at increased risk of disease returning
  • Tackling cancer’s biggest challenge
  • Untangling the evolution of cancer
  • Combining imaging and gene analysis could transform breast cancer diagnosis
  • Single agent doxorubicin therapy for sarcoma
  • The ICR identity project
  • New drug type could boost chemotherapy
  • High quality of our clinical trials confirmed
  • Clinical trial tests new combination treatment for advanced prostate cancer
  • Funding injection into prostate cancer research
  • The ICR turns up the heat on tumour cells
  • The promise of immunotherapy - and bridging the funding gap
  • The Story of Abiraterone
  • Featured Article Archive

Plan for action to fight global cancer unveiled

04 Feb 2013

A 10-point plan to turn back the tide on cancer has been published to mark World Cancer Day. Developed by the World Oncology Forum, including the ICR's Professor Stan Kaye, the plan calls for more focus on research, and for governments around the world to invest in better healthcare systems to help reduce the number of people dying from the disease.

Read more >>

New Tumour Profiling Unit signals push for personalised cancer treatment

29 Jan 2013

A new Tumour Profiling Unit at the ICR will accelerate the development of personalised cancer treatments and their delivery to patients.

Read more >>

Launch of trial of 'master switch' drug to treat several cancer types

16 Jan 2013

Cancer Research UK and its commercial arm Cancer Research Technology (CRT) are launching a trial of an experimental drug shown to simultaneously block many enzymes that control cancer cell growth and death. The early-stage Phase I clinical trial of up to 40 patients will be carried out by the ICR, and The Royal Marsden Hospital.

Read more >>

'Virtual experiments' aid scientists to find missing cancer targets

31 Dec 2012

Scientists have identified 46 previously overlooked but potentially ‘druggable’ cancer targets, using a powerful new online approach that allows researchers to carry out ‘virtual experiments’ to quickly prioritise which are the best targets for drug discovery.

Read more >>

 
 
Medication

  

See 2013 Press Release Archive


  • Contacts  | 
  • Privacy  | 
  • Terms and Conditions  | 
  • Accessibility  | 
  • Feedback  | 
  • Cookies  | 
  • Status
  • ICR News RSS Feed
  • Find us on Facebook
  • Follow us on Twitter